Online

What’s Our First Priority in Clinical Research: Generating Data or Protecting Participants?

Is the primary goal of clinical research to protect participants or to generate scientifically sound data? In this thought-provoking on-demand session, Dr. Jerry Menikoff explores this ethical dilemma and its impact on the future of clinical trials.

讲师团队

Jerry  Menikoff

Jerry Menikoff

Professor, NUS Centre for Biomedical Ethics, United States

Karla  Childers, MS

Karla Childers, MS

Head, Bioethics-Based Science and Technology Policy, Johnson & Johnson, United States

Karla Childers is Head, Bioethics-based Science & Technology Policy in the Johnson & Johnson Office of the Chief Medical Officer. Her primary responsibility is leading and coordinating various bioethics-based, science policy projects since 2013. Her longest running responsibility has been the support and coordination of J&J’s Clinical Trial Data Transparency Initiative. She is the Chair of the J&J Bioethics Committee and serves as a bioethics subject matter expert for internal and external policy work. Ms. Childers began her career in industry as a chemist and then project manager for global drug development teams. Ms. Childers is also the co-chair of the DIA Bioethics Community.

Lindsay  McNair, MD, MPH, MS

Lindsay McNair, MD, MPH, MS

Principal Consultant, Equipoise Consulting, United States

Lindsay McNair, MD, MPH, MSB is Principal Consultant at Equipoise Consulting. She was previously the Chief Medical Officer for WCG. In role she oversaw WCG IRB, and provided consultation to institutions and biopharma companies on a wide range of issues related to clinical protocol design, regulatory compliance, human subject protection, and ethical policy development. Prior to joining WCG, she was a consultant to pharmaceutical and biotechnology companies, providing medical oversight of all phases of clinical trials.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。